Scilex Holding Co also files under VCKAU; those filings are included. Filings under SCLX by Sino Clean Energy Inc (CIK 0001120096) from Sep 18, 2007 to Mar 5, 2010 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 3, 2026 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 500K | — | — |
| Apr 17, 2026 | Ma Stephen Hoi | CFO, COO and Secretary, Director | Buy(P) | 650K | $0.15 | $100K |
| Apr 17, 2026 | Ji Henry | Exec Chair, CEO and President, Director | Sell(S) | 650K | $0.15 | $100K |
| Apr 16, 2026 | Ji Henry | Exec Chair, CEO and President, Director | Buy(P) | 3.3M | $0.15 | $500K |
| Dec 30, 2025 | Scilex Holding Co | 10% Owner | Sell(S) | 9.7M | $0.54 | $5.2M |
| Dec 29, 2025 | Scilex Holding Co | 10% Owner | Sell(S) | 7.3M | $0.66 | $4.8M |
| Dec 26, 2025 | Scilex Holding Co | 10% Owner | Sell(S) | 3.7M | $0.75 | $2.8M |
| Oct 8, 2025 | Chun Jay | Director | Grant(A) | 20K | — | $0 |
| Oct 8, 2025 | Ma Stephen Hoi | CFO and COO, Director | Grant(A) | 60K | — | $0 |
| Oct 8, 2025 | Wu Yue Alexander | Director | Grant(A) | 20K | — | $0 |
| Oct 8, 2025 | Followwill Dorman | Director | Grant(A) | 20K | — | $0 |
| Oct 8, 2025 | Ji Henry | CEO and President, Director | Grant(A) | 120K | — | $0 |
| Jan 21, 2025 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 3.3M | — | — |
| Jan 16, 2025 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 779K | — | — |
| Jan 2, 2025 | SCLX Stock Acquisition JV LLC | 10% Owner | Other(J) | 5.0M | — | — |
| Dec 18, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 30K | $0.46 | $14K |
| Dec 16, 2024 | Followwill Dorman | Director | Grant(A) | 100K | — | $0 |
| Dec 16, 2024 | Wu Yue Alexander | Director | Grant(A) | 100K | — | $0 |
| Dec 16, 2024 | Chun Jay | Director | Grant(A) | 100K | — | $0 |
| Oct 31, 2024 | Ji Henry | Executive Chairperson, Director | Buy(P) | 9K | $0.94 | $8K |
| Oct 29, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 32K | $0.99 | $32K |
| Oct 18, 2024 | Followwill Dorman | Director | Buy(P) | 1K | $0.99 | $990 |
| Oct 18, 2024 | Chun Jay | Director | Buy(P) | 5K | $0.95 | $5K |
| Oct 17, 2024 | Ji Henry | Executive Chairperson, Director | Buy(P) | 10K | $0.97 | $10K |
| Oct 17, 2024 | Wu Yue Alexander | Director | Buy(P) | 20K | $0.95 | $19K |
| Oct 17, 2024 | Lemus David | Director | Buy(P) | 2K | $0.90 | $2K |
| Oct 16, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 30K | $0.99 | $30K |
| Oct 16, 2024 | Ma Stephen Hoi | Chief Financial Officer | Buy(P) | 7K | $0.97 | $6K |
| Aug 16, 2024 | Navani Annu | Director | Grant(A) | 250K | — | $0 |
| Jun 26, 2024 | Followwill Dorman | Director | Option exercise(M) | 1K | $1.37 | $1K |
| Jun 26, 2024 | Followwill Dorman | Director | Option exercise(M) | 1K | — | $0 |
| Jun 20, 2024 | Wu Yue Alexander | Director | Option exercise(M) | 5K | — | $0 |
| Jun 20, 2024 | Chun Jay | Director | Option exercise(M) | 5K | — | $0 |
| Jun 20, 2024 | Ma Stephen Hoi | Chief Financial Officer | Option exercise(M) | 2K | $1.41 | $3K |
| Jun 20, 2024 | Ma Stephen Hoi | Chief Financial Officer | Option exercise(M) | 2K | — | $0 |
| Jun 20, 2024 | Wu Yue Alexander | Director | Option exercise(M) | 5K | $1.41 | $7K |
| Jun 20, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 14K | $1.73 | $24K |
| Jun 20, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 14K | — | $0 |
| Jun 20, 2024 | Chun Jay | Director | Option exercise(M) | 5K | $1.41 | $7K |
| Jun 18, 2024 | Ji Henry | Executive Chairperson, Director | Option exercise(M) | 6K | $1.41 | $8K |
| Jun 18, 2024 | Ji Henry | Executive Chairperson, Director | Option exercise(M) | 6K | — | $0 |
| Jun 14, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 33K | $1.41 | $47K |
| Jun 14, 2024 | Shah Jaisim | See Remarks, Director | Option exercise(M) | 33K | — | $0 |
| May 17, 2024 | Chun Jay | Director | Buy(P) | 58K | $0.90 | $52K |
| May 17, 2024 | Ma Stephen Hoi | Chief Financial Officer | Buy(P) | 14K | $0.88 | $12K |
| May 17, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 57K | $0.92 | $52K |
| May 17, 2024 | Ji Henry | Executive Chairperson, Director | Buy(P) | 50K | $0.88 | $44K |
| May 16, 2024 | Shah Jaisim | See Remarks, Director | Buy(P) | 83K | $0.84 | $70K |
| Mar 15, 2024 | Followwill Dorman | Director | Grant(A) | 100K | — | $0 |
| Mar 15, 2024 | Lemus David | Director | Grant(A) | 100K | — | $0 |
| Oct 4, 2023 | Ji Henry | Executive Chairperson, Director | Grant(A) | 200K | — | $0 |
| Oct 4, 2023 | Chun Jay | Director | Grant(A) | 250K | — | $0 |
| Oct 4, 2023 | Wu Yue Alexander | Director | Grant(A) | 250K | — | $0 |
| Oct 4, 2023 | Shah Jaisim | See Remarks, Director | Grant(A) | 200K | — | $0 |
| Oct 4, 2023 | Ma Stephen Hoi | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Sep 21, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Sell(S) | 4.5M | — | — |
| Sep 21, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Sell(S) | 60.1M | — | — |
| Mar 17, 2023 | Ji Henry | Executive Chairperson, Director | Other(J) | 3K | $8.60 | $23K |
| Jan 19, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Other(J) | 73.7M | — | $0 |
| Jan 17, 2023 | Thompson Tommy G | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Followwill Dorman | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Czerepak Elizabeth | See Remarks | Grant(A) | 350K | — | $0 |
| Jan 17, 2023 | Lemus David | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Hamill Laura | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Lee Tien-Li | Director | Grant(A) | 250K | — | $0 |
| Jan 17, 2023 | Ji Henry | Executive Chairperson, Director | Grant(A) | 9.0M | — | $0 |
| Jan 17, 2023 | Shah Jaisim | See Remarks, Director | Grant(A) | 1.7M | — | $0 |
| Dec 2, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 225K | $0.35 | $79K |
| Nov 25, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 46K | $0.44 | $20K |
| Nov 23, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 443K | $0.40 | $177K |
| Nov 22, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Buy(P) | 673K | $0.23 | $155K |
| Nov 10, 2022 | Ho Chris | Insider | Other(J) | 5.3M | — | — |
| Nov 10, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Other(J) | 307K | — | — |
| Nov 10, 2022 | Sorrento Therapeutics, Inc. | 10% Owner | Other(J) | 2.8M | — | — |
| Nov 10, 2022 | Ho Chris | Insider | Other(J) | 578K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Scilex Holding Co, SEC CIK 0001820190. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SCLX and shows every filing by that issuer (also filed as VCKAU). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SCLX